Vetoquinol (France) Top Management

VETO Stock  EUR 77.80  0.40  0.51%   
Vetoquinol employs about 2.6 K people. The company is managed by 10 executives with a total tenure of roughly 44 years, averaging almost 4.0 years of service per executive, having 262.1 employees per reported executive. Analysis of Vetoquinol's management performance can provide insight into the company performance.
Matthieu Frechin  CEO
CEO, Director and Member of Strategy Committee
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vetoquinol. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Vetoquinol Management Team Effectiveness

The company has return on total asset (ROA) of 0.0774 % which means that it generated a profit of $0.0774 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.11 %, meaning that it generated $0.11 on every $100 dollars invested by stockholders. Vetoquinol's management efficiency ratios could be used to measure how well Vetoquinol manages its routine affairs as well as how well it operates its assets and liabilities.

Vetoquinol Workforce Comparison

Vetoquinol is rated first in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 25,027. Vetoquinol retains roughly 2,621 in number of employees claiming about 10% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.09 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.14 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.14.

Vetoquinol Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Vetoquinol Price Series Summation is a cross summation of Vetoquinol price series and its benchmark/peer.

Vetoquinol Notable Stakeholders

A Vetoquinol stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Vetoquinol often face trade-offs trying to please all of them. Vetoquinol's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Vetoquinol's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Matthieu FrechinCEO, Director and Member of Strategy CommitteeProfile
Alain MassonCOO and Chief PharmacistProfile
Hans HollegienMember of the Executive Committee, Group Director - Marketing and CommunicationProfile
Isabelle ProustCabreraMember of the Executive Committee, Group Director - Human ResourcesProfile
Dominique DerveauxMember of the Executive Committee, Group Director - EuropeProfile
Regis MonteilGroup Director of Fin. and LegalProfile
Philippe GruetChief OfficerProfile
Xavier BerthetDirector CommunicationsProfile
Laurent ThoreLegal PartnershipsProfile
Sandrine PerrierChief OfficerProfile

About Vetoquinol Management Performance

The success or failure of an entity such as Vetoquinol often depends on how effective the management is. Vetoquinol management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Vetoquinol management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Vetoquinol management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. Vetoquinol SA was founded in 1933 and is headquartered in Lure, France. Vetoquinol operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. It employs 2004 people.
Please note, the presentation of Vetoquinol's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Vetoquinol's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Vetoquinol's management manipulating its earnings.

Vetoquinol Workforce Analysis

Traditionally, organizations such as Vetoquinol use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Vetoquinol within its industry.

Vetoquinol Manpower Efficiency

Return on Vetoquinol Manpower

Revenue Per Employee198.9K
Revenue Per Executive52.1M
Net Income Per Employee24K
Net Income Per Executive6.3M
Working Capital Per Employee58K
Working Capital Per Executive15.2M

Complementary Tools for Vetoquinol Stock analysis

When running Vetoquinol's price analysis, check to measure Vetoquinol's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vetoquinol is operating at the current time. Most of Vetoquinol's value examination focuses on studying past and present price action to predict the probability of Vetoquinol's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vetoquinol's price. Additionally, you may evaluate how the addition of Vetoquinol to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Transaction History
View history of all your transactions and understand their impact on performance